At the San Antonio Breast Cancer Symposium, researchers presented findings on Clarity BCR, a multimodal multitask ...
AI promises a smarter, faster, more efficient future, but beneath that optimism lies a quiet problem that’s getting worse: the data itself.
News-Medical.Net on MSN
AI model improves recurrence risk stratification in HR-positive, HER2-negative breast cancer
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...
At the San Antonio Breast Cancer Symposium, researchers presented a study on a multimodal artificial intelligence model that integrated clinical data, pathology-based imaging, and expanded molecular ...
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...
The ICM+ AI model demonstrated superior prognostic value for breast cancer recurrence compared to Oncotype DX, especially for late distant recurrences. Integration of pathomic imaging in the ICM+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback